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WHAT CAN WE LEARN FROM THE PORTUGUESE
DECRIMINALIZATION OF ILLICIT DRUGS?
Caitlin Elizabeth Hughes* and Alex Stevens
The issue of decriminalizing illicit drugs is hotly debated, but is rarely subject to evidence-based
analysis. This paper examines the case of Portugal, a nation that decriminalized the use and pos-
session of all illicit drugs on 1 July 2001. Drawing upon independent evaluations and interviews
conducted with 13 key stakeholders in 2007 and 2009, it critically analyses the criminal justice and
health impacts against trends from neighbouring Spain and Italy. It concludes that contrary to
predictions, the Portuguese decriminalization did not lead to major increases in drug use. Indeed,
evidence indicates reductions in problematic use, drug-related harms and criminal justice
overcrowding. The article discusses these developments in the context of drug law debates and
criminological discussions on late modern governance.
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Introduction
Efforts to improve criminal justice policy responses to drug use and distribution have
led to frequent and often heated discussions around the necessity of applying crim-
inal penalties and themerits of a number of alternate legislative approaches (see, e.g.
discussions in Australia, the United Kingdom and the United States), including le-
galization, decriminalization and depenalization. These terms are often used erro-
neously and interchangeably. For the purposes of the current article, we define each
as the following: legalization is defined as the complete removal of sanctions, making
a certain behaviour legal and applying no criminal or administrative penalty; decrim-
inalization is defined as the removal of sanctions under the criminal law, with op-
tional use of administrative sanctions (e.g. provision of civil fines or court-
ordered therapeutic responses); and depenalization is the decision in practice
not to criminally penalize offenders, such as non-prosecution or non-arrest. These
forms of regulation of currently illicit substances are often discussed, but are rarely
tested in practice.
Political reluctance to reform drug laws has been clearly demonstrated in recent years
in the United Kingdom. Despite international evidence that rates of drug use are not
directly affected by harsher punishment of drug users (Reuter and Stevens 2007;
Degenhardt et al. 2008) (and pressure from multiple advocates), the British Govern-
ment has firmly opposed any move towards decriminalization. Politicians have warned
that decriminalization of cannabis would ‘send the wrongmessage’ (Home Affairs Com-
mittee Inquiry into Drug Policy 2002: para. 74). Some researchers (McKeganey 2007;
Inciardi 2008; Singer 2008) have supported this argument, arguing that removing
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criminal penalties would lead to increased drug use, with harms falling hardest on the
deprived communities that are already the most damaged by drug-related problems.
However, most public arguments are based on speculation rather than the available
evidence on effects.
The predominance of speculation over evidence can be attributed to a number of
factors. First, the United Nations conventions on illicit drugs require that nation
states prohibit illicit drug cultivation, manufacturing, sale and possession. They
therefore limit the possibility of experimentation with alternative modes of regula-
tion. There is some ‘room for manoeuvre’ (Dorn and Jamieson 2001), as shown by the
use of various forms of decriminalization and depenalization in the United States,
Italy, Spain, the Czech Republic, Germany, Australia and the Netherlands. A second
limit to the use of evidence in debates over drug regulation is the limited and variable
evidence surrounding the impacts of these existing forms of liberalization. Where
reforms that have been studied, different methods and approaches have been used
(Model 1993; Donnelly et al. 1995; McDonald and Atkinson 1995; Sutton and
McMillan 1998; Lenton et al. 1999; Single et al. 2000; Solivetti 2001; Kilmer 2002; Korf
2002; Pacula et al. 2004; Williams 2004; Featherston and Lenton 2007; Domrongplasit
et al. 2010; Reinarman 2009). To date, the major focus of analysis has been whether
decriminalization leads to increases in the prevalence of drug use. Most studies
have found there are no significant increases in use (e.g. Donnelly et al. 1995;
1999; Featherston and Lenton 2007). Others have found a slight increase (e.g.
Williams 2004; Zhao and Harris 2004; Damrongplasit et al. 2010). Still others have
shown how difficult it is to make any certain judgment on the effects of decriminal-
ization on drug use, given the absence of adequate comparators (Pacula et al. 2004;
Hughes 2009).
Social and criminal justice impacts have also been mixed. One of the best studied
reforms has been the South Australian cannabis expiation notice scheme introduced
in 1987. Evaluators found that ‘decriminalization’ led to increased employment pros-
pects and increased trust of police (Lenton et al. 1999). Yet, it also led to net-widening.
More people received formal contact with the criminal justice system than prior to the
reform (Sutton and McMillan 1998). In fact, there was a 280 per cent increase in ex-
piable cannabis offences, which meant there was an overall increase in the burden
on the criminal justice system (Christie and Ali 2000).
The most comprehensive synthetic review of the impacts of the decriminalization of
illicit drugs has been conducted by MacCoun and Reuter (2001a), using data from the
Netherlands, United States, Australia and Italy. They concluded that the removal of
criminal penalties appeared to produce positive but slight impacts. The primary impact
was reducing the burden and cost in the criminal justice system. This also reduced the
intrusiveness of criminal justice responses to users. The removal of criminal penalties
alone had little or no impact on the prevalence of drug use or drug-related health
harms. The extent of additional use depended rather on the extent to which there
was commercial promotion. They used the example of the Netherlands, where the rise
in cannabis use did not immediately follow its depenalization, but coincided with the
development of ‘coffee shops’ that openly promoted their illicit wares (MacCoun and
Reuter 2001b).
Their analysis came too early to include the Portuguese move towards decriminaliza-












attention, as it is a comprehensive form of decriminalization, with the possession of all
drugs, when deemed for personal use,1 now considered to be an administrative rather
than a criminal offence. Equally importantly, one key rationale for the reform was to
provide a more health-oriented response, including the possibility to refer people
who are dependent on drugs into treatment. Many of the reforms in other countries
simply seek, in contrast, to avoid criminal penalties for drug users.
The Portuguese reform has now been in force for almost nine years—time enough to
measure the effects. There have since been two studies published by thinktanks on the
impacts of the Portuguese policy (Hughes and Stevens 2007; Greenwald 2009), but so
far, no reports on it have appeared in English peer-reviewed journals. The authors of this
current paper have both had the good fortune to be involved in examining this reform
for a number of years. In this article, we aim:
(1) to describe the Portuguese reform;
(2) to provide an overview of the health and criminal justice impacts;
(3) to discuss the contribution of this reform and this research to the existing state of
knowledge on decriminalization.
The Portuguese Decriminalization and Drug Action Plan
Portugal’s location on the south-western border of Europe makes it a gateway for drug
trafficking. It is a transit nation for trafficking of cocaine from Brazil andMexico, heroin
from Spain, hashish from Morocco and liamba (the local word for herbal cannabis)
from Southern Africa. Across drug types, it is estimated that 77 per cent of drugs seized
in Portugal are destined for the external market (i.e. other European countries) (In-
stitute for Drugs and Drug Addiction 2008). The two biggest challenges are cocaine
and hashish. For example, the United Nations Office on Drugs and Crime (2008) noted
that during 2006, Portugal was responsible for 35 per cent of all cocaine seizures in
Europe, making it second in seizures only to Spain.
Lifetime prevalence of illicit drugs has historically been low in Portugal. In 2001, only
7.8 per cent of 15–64-year-olds in Portugal had ever used an illicit drug (Balsa et al. 2004).
In contrast, the British Crime Survey reported that in 2001/02, 34 per cent of 16–59-year-
olds in the United Kingdom had used an illicit drug (Aust et al. 2002). However, there
was in the late 1980s and 1990s a significant population of intravenous heroin users, who
obtained their drugs through open-air drug markets that became notorious. Rates of
infectious diseases including HIV, AIDS, Tuberculosis, Hepatitis B and C soared. For
example, between 1990 and 1997, the number of known drug users living with AIDS
increased from 47 to 590 (Instituto da Droga e da Toxicodependeˆncia 2004b). By
1999, Portugal had the highest rate of drug-related AIDS in the European Union
and the second highest prevalence of HIV amongst injecting drug users (EMCDDA
2000). Drug-related deaths had increased in Portugal to a peak of 369 in 1999 (an in-
crease of 57 per cent since 1997) (Instituto Portugueˆs da Droga e da Toxicodependeˆncia
2000). There was also growing concern over the social exclusion and marginalization of
drug users, and a perception from many areas of society including the law enforcement
1Possession for the purposes of supply remains a criminal offence.











and health sectors that the criminalization of drug use was increasingly part of the prob-
lem, not the solution (Hughes 2006).
It was within this context2 that a government-appointed expert commission proposed
to decriminalize illicit drugs for personal use and to introduce Portugal’s first national
drug strategy, which had the explicit goal of providing a more comprehensive and ev-
idence-informed approach to drug use (Comissa˜o para a Estrate´gia Nacional de Com-
bate a` Droga 1998). The legislative reform and new national drug strategy were seen as
critically linked: the decriminalization sought to provide a more humane legal frame-
work, and by expanding policies and resources across the areas of prevention, harm
reduction, treatment, social reintegration and supply reduction, the strategy sought
to open up new ways for the field to respond, such as through channelling minor drug
offenders through to the drug treatment system. Both sets of recommendations were
adopted almost in full (for full details, seeHughes 2006) and Portugal commenced their
ambitious reform by rolling out the national strategy and expanded resources in May
1999. Subsequently, on 1 July 2001, the decriminalization entered into force.
Prior to the 2001 reform, drug possession, acquisition and cultivation when for per-
sonal use were criminal offences punishable with up to 1 year’s imprisonment (Decreto-
Lei no. 15/93, de 22 de janeiro 1993).3 But with the introduction of Law 30/2000, drug
possession and acquisition became a public order or administrative offence (Lei n. 30/
2000, de 29 de novembro 2000). The new offences are sanctioned through specially
devised Commissions for the Dissuasion of Drug Addiction (CDTs).
The CDTs are regional panels made up of three people, including lawyers, social work-
ers and medical professionals. Alleged offenders are referred by the police to the CDTs,
who then discuss with the offender the motivations for and circumstances surrounding
their offence and are able to provide a range of sanctions, including community service,
fines, suspensions on professional licenses and bans on attending designated places.
However, their primary aim is to dissuade drug use and to encourage dependent drug
users into treatment. Towards this end, they determine whether individuals are depen-
dent or not. For dependent users, they can recommend that a person enters a treatment
or education programme instead of receiving a sanction. For non-dependent users, they
can order a provisional suspension of proceedings, attendance at a police station, psy-
chological or educational service, or impose a fine. The panel members of the CDTs are
supported by staff employed by the Instituto da Droga e da Toxicodependeˆncia (IDT,
the Institute for Drugs and Drug Addiction), the central government agency on drugs.
The new law applies to use/possession of all illicit drugs—including cannabis, heroin
and cocaine—but it is restricted to use/possession of up to ten days’ worth of a drug.
This amounts in practice to 0.1 g heroin, 0.1 g ecstasy, 0.1 g amphetamines, 0.2 g cocaine
or 2.5 g cannabis (Decreto-Lei n. 15/93, de 22 de janeiro 1993; Portaria n. 94/96, de 26
de Marcxo 1996). Individuals found with more than this quantity will be charged and
referred to the courts, where they may face charges for trafficking or trafficking/con-
sumption (where the offender is found in possession of more than the consumer
amount, but deemed to have obtained plants, substances or preparations for personal
use only) (Decreto-Lei n. 15/93, de 22 de janeiro 1993).
2The process of reform is inevitably complex. A full description of the context, drivers and initial impressions can be found in
Hughes (2006).












Following internal and external evaluations in 2004 (Instituto da Droga e da Toxico-
dependeˆncia 2004a; Instituto Nacional de Administracxa˜o 2004), the decriminalization
and the strategy have been extended. The current strategy, entitled ‘A National Plan
Against Drugs and Drug Addiction’, is set to continue until 2012 (Instituto da Droga
e da Toxicodependeˆncia 2005).
Methods
For this analysis of the effects of the Portuguese policy, we have carried out a thorough
review of all the available Portuguese evaluative documents, including the annual na-
tional reports of the IDT from 1998 to 2008 and the internal and external evaluations
that they have carried out and commissioned. To supplement these data, we carried out
interviews with 13 key informants in late 2007 and late 2009. The key informants were
sampled purposively in order to canvass the key areas of health and criminal justice as
well as politicians, bureaucrats from the IDT and non-government advocates. The
final sample included the head of the Institute for Drugs andDrug Addiction, IDTmem-
bers involved in research and overseeing the CDTs, plus representatives of the non-
governmental AIDS and drug-user organizations, politicians from the left and right
wings (Populist Party and Social Democratic Party), academics and representatives of
the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). While
no member of the criminal justice system was willing/able to take part, one stakeholder
was a former police officer and another an overseer of CDT implementation; both were
able to comment on criminal justice-related issues. Semi-structured interviews were con-
ducted with key informants in English or Portuguese (with the aid of a fluent translator).
Interviews lasted 45–90 minutes and covered the health, social and criminal justice
impacts from the reform and perceived strengths and failings from the reform.
Analysis of policies and their impacts in foreign countries pose a number of unique
challenges for authors in obtaining access to data and subjects and in the interpretation
of the results. For example, Nelken (2009) has argued that one particular risk is of eth-
nocentrism over definitions of key terms and policy rationales. This work built on prior
research into the process and impacts of the Portuguese decriminalization that was car-
ried out by Hughes (2006) between 2002 and 2006. During this process, the primary
author had become proficient in reading and speaking Portuguese and collaborated
with the IDT. Research for the existing research also utilized the support and feedback
from those based in the IDT. These measures should reduce the risk of external bias.
There are several limitations to thesemethods. Themost important for any evaluation
of national drug policy is the absence of a control comparison; there is no counter-
factual Portugal, which did not decriminalize drugs in 2001. One way of countering this
is by comparing trends from the chosen nation (Portugal) with that of nations that did
not undertake the reform. We have therefore used annual data reported to the
EMCDDA to analyse Portuguese trends in light of trends from neighbouring Spain
and/or Italy, subject to data availability. The comparators fall into the same geographic
region, thereby allowing for the detection of regional trends. Moreover, while Italy and
Spain have adopted similar drug policies, namely by introducing administrative sanc-
tions for drug use in 1990 and 1992, respectively (for an overview, see EMCDDA
2005), neither country implemented any radical overhauls during the period of study
(Reitox National Focal Point 2008; EMCDDA 2009a).











Further limitations were that the impacts of decriminalization—particularly the
actions of the CDTs—were also contingent upon the operation of a number of other
organizations, including the police and drug treatment services. Moreover, implemen-
tation of the national plan and decriminalization has not been constant. While this was
attributable in part to learning and adaptation, unforeseen issues also arose. For key
informants, the biggest challenge in understanding the long-term effects of the reform
has been a series of decisions to not replace core CDT staff if they retired. This meant
that at times between 2005 and 2008, up to 38 per cent of the CDTs, including the most
frequented CDT in Lisbon, were non-operational.4
There are additional challenges relating to data availability and interpretation. Drug
use, market changes and drug-related crime is notoriously hard to measure by any
means. Our qualitative research also has limitations. The sample size was not large
enough to reach data saturation and neither were we able to interview police or criminal
justice representatives. Our intention is not to present the interview data as reflecting
the full range of public, professional and political opinion, but to use it to supplement
and interrogate the data collected from the national documentation.
All these challenges make it impossible to attribute any changes in drug use or related
harm directly to the fact or form of the Portuguese decriminalization. However, we can
test the hypotheses from some politicians and academics (cited above) that decriminal-
ization necessarily leads to increases in drug use and related harms.
Implementation of the Decriminalization
Since 2002, the CDTs have initiated about 6,000 administrative processes against drug
users per year, with the number trending upwards to 6,543 processes in 2008 (Instituto
da Droga e da Toxicodependeˆncia 2009). Based on estimates of current demand (see
latter sections), this represents approximately 2.5 per cent drug users in Portugal.5 Most
of the referred drug users are male (94 per cent) and between the ages of 16–24 (47 per
cent) and 25–34 (31 per cent).
The number of processes that have been decided upon or ‘finalized’ decreased be-
tween 2003 and 2006, which meant there was an overall decline in the proportion of
cases in which drug users received an administrative sanction from the CDTs (from
75 per cent in 2003 to 48 per cent in 2006). While this trend has been reversed in recent
years, it has decreased the capacity to sanction or refer drug users to treatment. The
decline in finalized processes was linked to the reduction in operational CDTs (Instituto
da Droga e da Toxicodependeˆncia 2009). As ofmid 2008, all CDTs, with the exception of
Vila Real, were back in operation.
Since 2001, most cases have involved only use—acquisition or possession of cannabis
or heroin. The proportion involving heroin decreased from 33 per cent in 2001 to 14 per
cent in 2006 (and remains at 13 per cent in 2008) (Instituto da Droga e da Toxicode-
pendeˆncia 2009). Conversely, the proportion involving cannabis increased from 53 per
4There are differences of opinion as to what caused this process, including political motivations and a recession, but the end result
is that many offenders received no ‘formal’ action, whether by way of sanction or referral for treatment.
5The 2007 data estimated 3.7 per cent population aged 15–64 used any illicit drug in the last year (Balsa et al. 2007) = approx-













cent in 2001 to 70 per cent in 2006, decreasing to 64 per cent in 2008. These reflect
trends in drug use, particularly a decline in heroin use (see below). The major sanction
used by the CDTs has been the provisional suspension of proceedings for individuals
who are deemed non-dependent on illicit drugs. These have been used in 59–68 per
cent of cases per year. Perhaps due to the decline in offenders being seen for heroin,
the use of provisional sanctions with treatment (for dependent individuals) has de-
creased since the first full year of operation (31 per cent in 2002) and made up only
18 per cent of sanctions in 2008. Conversely, the use of punitive sanctions such as warn-
ings, bans on attending designated places or requirements to visit the CDTs has in-
creased (from 3 per cent in 2002 to 15 per cent in 2008). This has been attributed
in part to the lack of appropriate treatment options in Portugal to which to refer
non-heroin dependent drug users.6
According to the stakeholders that we interviewed, the CDTs provided a number of
advantages, including: earlier intervention for drug users by a specialist panel of experts;
the provision of a broader range of responses; increased emphasis on prevention for
occasional users; and increased provision of treatment and harm-reduction services
for experienced and dependent users. While these advantages were often dependent
upon the conjoint increase in collaboration and expansion of treatment places, decrim-
inalization was deemed to have played a vital role. But, due to the problems cited above,
namely the lack of full staff in all CDTs and the lack of appropriate interventions to
which to refer young and occasional drug users, stakeholders said the full potential
of the reform had not been reached.
There are few data on which to assess the long-term impacts of the CDT process. For
example, while it is known that only 5–6 per cent of offenders have been referred to
a CDT twice in any one year, figures have not yet been collected on prior or subsequent
offending and drug use amongst those referred through the CDTs. The IDTreported in
September 2009 that it now plans to start collecting such data. Other data can neverthe-
less be used to test health, criminal justice and social impacts on the broader population.
Trends Associated with the Decriminalization
Reported drug use in general population and specific sub-groups
The most controversial impact of the Portuguese decriminalization has been in regards
to drug use. Key stakeholders in Portugal were in general agreement that there has been
small to moderate increases in overall reported drug use among adults. Yet, there were
differences as opinion regarding three issues, namely whether the reported increase is:
real, significant/concerning and attributable to the reform.
Critics have argued that the decriminalization had led to a perception of acceptability
of illicit drug use and caused an increase in illicit drug use, particularly cannabis. Yet,
supporters have argued that apparent increases are largely spurious. They may reflect
increased reporting of use due to a reduction in the stigma associated with drug use. They
may also reflect broader international or regional trends in drug use and hence not be
specifically attributable to the Portuguese reform. The final and most complex part of
6Best-practice evidence suggests that the most effective treatment response for cannabis-dependent users is a ‘brief intervention’
involving six sessions of cognitive behavioural therapy, yet this is not currently provided in Portugal (see, e.g. Copeland et al. 2001).











the issue is a value judgment concerning whether any increases in apparently recrea-
tional use are significant and whether the decriminalization has led to an overall wors-
ening of the drug problem in Portugal. The absence of general population surveys prior
to 2001makes it difficult to see trends over time in Portugal and in particular to examine
the effects of the decriminalization itself. Moreover, we lack data on current or prior
likelihood of reporting drug use in Portugal. Nevertheless, we can examine the trends
in three relevant sub-populations—the adult population, youth and problematic drug
users—and, in so doing, explore which hypothesis has the most support. We judge
trends in problematic use to be particularly important, as any apparent increase is po-
tentially much more deadly and costly.
Between 2001 and 2007, lifetime and last-year use was reported to have increased in
Portugal for almost all illicit substances (see Tables 1 and 2). The increase was seen in all
age groups above 19 (Balsa et al. 2004; 2007).
Portuguese trends largely mimicked the trends observed in neighbouring Spain and
Italy (see Tables 3 and 4). All three nations reported increases in lifetime prevalence of
hashish, amphetamines and cocaine as well as increases in the last year prevalence of
cannabis and cocaine use. The congruity with the other data from neighbouring nations
provides little evidence that any apparent increases were directly attributable to the
decriminalization.
Data from a European drug survey amongst 15–16-year-olds conducted before and
after the decriminalization provide additional insight into the likely trends in lifetime
use.7 Amongst Portuguese youth (see Figure 1),8 reported lifetime use of most illicit
drugs increased in the lead-up to and immediately following the decriminalization,
but then declined (Hibell et al. 2009). This was very similar to the trends observed
in Italy and in broader Europe, with the major differences being that the 2003–07 de-
cline in reported use of any illicit substance appears more pronounced in Portugal and
the decline in reported cannabis use appears less pronounced in Portugal.
Problematic drug use was the major concern at the commencement of the decrim-
inalization process and national drug strategy. Since the adoption of the reform, the
prevalence of problematic drug use (PDU), particularly intravenous drug use, in Por-
tugal is estimated to have declined. Using a multiplier method, based on the number of
drug users in treatment,9 Negreiros andMagalha˜es (2009) calculated that between 2000
and 2005 the estimated number of problematic drug users in Portugal reduced from 7.6
to 6.8 per 1,000 population aged 15–64 years. That said, the overlap in ranges (from 6.8–
8.5 in 2000 to 6.2–7.4 in 2005) means that any decline has not been statistically signif-
icant. The more significant finding was a fall in the estimated prevalence of injecting
drug use (from a mean of 3.5 to 2.0 injecting drug users per 1,000 population aged 15–
64 or a range of 2.3–4.6 to 1.8–2.2).
This trend is notable given that the number of problematic drug users in Italy is
thought to have gone in the opposite direction. Indeed, between 2001 and 2007,
the estimated number of problematic drug users in Italy increased from 6.0 to 8.6
7Unfortunately, data on last-year use, a more relevant indicator of current drug usage patterns, was not collected in the European
School survey Project on Alcohol and other Drugs (ESPAD).
8The apparent increase in the use of heroin between 2003 and 2007 is within the statistical margin for error of this survey. The
trend in Portugal is similar to that observed in Eastern Europe, such as Croatia and Slovenia.
9Themultiplier method is one of three mainmethods currently used to derive estimates of problematic drug users in Europe. For












per 1,000 population aged 15–64 (calculated using multivariate indicator method)
(EMCDDA 2009b). Even in Spain, where the number of problem opiate users is esti-
mated to have declined, estimates from 2006 suggest the overall number of problematic
TABLE 1 Prevalence of lifetime illicit drug use in Portugal amongst individuals aged 15–64, by drug type, 2001
and 2007
Drug 2001 2007 Change
Any illicit substance 7.6 12.0 þ4.4
Hashish 7.6 11.7 þ4.1
Cocaine 0.9 1.9 þ1.0
Ecstasy 0.7 1.3 þ0.6
Amphetamines 0.5 0.9 þ0.4
Heroin 0.7 1.1 þ0.4
Sources: Balsa et al. (2004; 2007).
TABLE 2 Prevalence of illicit drug use in Portugal in the last 12 months amongst individuals aged 15–64, by
drug type, 2001 and 2007
Drug 2001 2007 Change
Any illicit substance 3.4 3.7 þ0.3
Hashish 3.3 3.6 þ0.3
Cocaine 0.3 0.6 þ0.3
Ecstasy 0.4 0.4 0
Amphetamines 0.1 0.2 þ0.1
Heroin 0.2 0.3 þ0.1
Sources: Balsa et al. (2004; 2007).
TABLE 3 Prevalence of illicit drug use in Spain in the last 12 months amongst individuals aged 15–64, by drug
type, 2001 and 2007
Drug 2001 2007 Change
Hashish 9.7 10.1 þ0.4
Cocaine 2.6 3.1 þ0.5
Ecstasy 1.9 1.2 –0.7
Amphetamines 1.2 0.9 –0.3
Source: EMCDDA (2009b). NB. Data on use of heroin and any illicit substance were not reported.
TABLE 4 Prevalence of illicit drug use in Italy in the last 12 months amongst individuals aged 15–64, by drug
type, 2001 and 2007
Drug 2001 2007 Change
Hashish 6.2 14.6 þ8.4
Cocaine 1.1 2.2 þ1.1
Ecstasy 0.2 0.6 þ0.4
Amphetamines 0.1 0.4 þ0.3
Source: EMCDDA (2009b). NB. Data on use of heroin and any illicit substance were not reported.











drug users may also have increased, due to an increase in the number of problematic
cocaine users (Reitox National Focal Point 2008).
Thus, while general population trends in Portugal suggest slight increases in lifetime
and recent illicit drug use, studies of young and problematic drug users suggest that use
has declined. The similarity in general population and youth trends in Portugal, Italy
and Spain adds support for the argument that reported increases in general population
use in Portugal reflect regional trends and thus are not solely attributable to the decrim-
inalization. Moreover, the fact that Portugal is the only of these nations to have exhibited
declines in PDU provides strong evidence that the Portuguese decriminalization has not
increased the most harmful forms of drug use.
Burden on the criminal justice system
Most interviewees were of the view that the decriminalization had reduced the burden
on the Portuguese criminal justice system and enabled police to refocus their attention
on more serious offences, namely drug trafficking-related offences. Yet, in the early
years, there were also concerns of a rise in drug-related crime. We look here at impacts
on drug offences and drug-related crime.
Following the decriminalization, there was a substantial reduction in the number of
alleged drug offenders being arrested and sent to the criminal courts. Indeed, as shown
in Figure 2, the number of people arrested for criminal offences related to drug offences
reduced from over 14,000 offenders in 2000 to an average of 5,000–5,500 offenders per
FIG. 1 Lifetime prevalence of illicit drug use amongst school students in Portugal, Italy and the
European Union, aged 15–16, 1995–2007, by drug type and country.












year (Instituto da Droga e da Toxicodependeˆncia 2009).10 Equally importantly, the num-
ber of people detected under the new law for administrative drug use/possession offen-
ces has remained fairly constant at about 6,000 per year, thereby indicating no overall
increase in the amount of formal contact that drug offenders are having with Portuguese
police and so no net-widening.
This is a notable finding in light of the data from Spain (see Figure 3), where the
burden on the police has grown as a result of large increases in the number of offenders
detected through the administrative system for drug use/possession (since 1998) and
smaller increases in detections through the criminal system for drug trafficking (since
2004) (Reitox National Focal Point 2008). The data thus suggest that the Portuguese
decriminalization may have increased efficiency of police or court operations as they
became less crowded with drug offenders. Detailed studies would be needed to confirm
this.11
Regarding trends in drug-related crime, it was reported in the 2004 evaluation by the
central police agencies (Direccxa˜o Central de Investigacxa˜o do Tra´fico de Estupefacientes
2004) that the number of crimes strongly linked to drugs—that is theft, robberies, public
assaults and certain types of fraud—increased by 9 per cent between 1995–99 and 2000–
04. Themost notable increases were street robberies, theft frommotor vehicles and theft
FIG. 2 Number of offenders arrested in Portugal for trafficker, trafficker–consumer and consumer
offences by type of offence, 1998–2008
Source: IDT (2009).
10As per the reform arrests before July 2001 include the offences for simple possession. After, they do not.
11Analysis of the impacts on the Portuguese courts is complicated due to substantial backlogs in court operations. Nevertheless,
there was a similar decline in the number of drug offenders convicted.











of motor vehicles, which increased by 66, 30 and 15 per cent, respectively. Conversely,
other forms of theft such as assaults/robberies from post offices and thefts from homes
and businesses (which were deemed strongly linked to drugs) declined by 60, 8 and 10
per cent, respectively. The report by the central police agencies concluded that there
had been an increase in more opportunistic crimes but a reduction in crimes that were
more complex, pre-mediated and likely to involve threats or use of violence (Direccxa˜o
Central de Investigacxa˜o do Tra´fico de Estupefacientes 2004). However, it did not attri-
bute any such changes to the decriminalization. Nor did it consider the possibility that
police officers spent the time they saved (from not arresting drug users) on boosting
reporting and recording other low-level crimes (for an overview of the difficulties in
assessing the cause and effects of changes in drug-related crime, see Seddon 2000;
da Agra 2002; Stevens 2007). Unfortunately, data on drug-related crime is not routinely
collected and hence it is not possible to identify more recent trends or to compare
trends in neighbouring Spain or Italy.
The proportion of drug-related offenders in the Portuguese prison population, that is
offences committed under the influence of drugs and/or to fund drug consumption,
has dropped from 44 per cent in 1999 to 21 per cent in 2008 (Instituto da Droga e da
Toxicodependeˆncia 2009). This has been very welcome, due to the historic overcrowd-
ing of Portuguese prisons. The prison density (prisoners per 100 prison places) of Por-
tuguese prisons fell from 119 in 2001 to 101.5 in 2005 (Council of Europe 2007). A
survey of drug use and related problems in prison found that between 2001 and
2007, the numbers of drug users and general rate of drug use within prisons had fallen
significantly (Torres 2009). For example, use of heroin prior to prison had fallen from
FIG. 3 Number of offenders arrested in Spain for trafficker and consumer offences, by type of offence,
1998–2007












44 to 30 per cent and use within prisons from 27 to 13 per cent. Rates of intravenous use
before and inside prison had also fallen, as had the prevalence of HIV amongst prison-
ers. Trends from Spain and Italy are not known, but this further suggests that even if
there were small increases in drug-related crime immediately following the reform,
there have been overall reductions in the burden of drug-related offenders on the
criminal justice system.
Drug seizures and prices
One question of interest is whether the decriminalization had a positive, negative or null
impact on the Portuguese drug market. Some local interviewees told us that one of the
aims of the decriminalization was to enable the police to shift resources from low-level
drug users to higher levels of the drug market. Key informants put forward a number of
views: first, that it contributed to a growth in the market and, second, that it contributed
to increased law enforcement capacity to make a dent in the market. For example, it was
suggested that while the police were initially wary that decriminalization would reduce
their ability to disrupt the drugmarket, they have found other apparently successful ways
to target drug traffickers. The best indicators that can be used to examine these hypoth-
eses come from data concerning seizures (number and amount of seizures) and retail
drug price.
From 1997 to 2008, there was limited change in the number of seizures of illicit drugs
in Portugal. The main exception was seizures of heroin, which declined from a peak in
1999 to a steady state in 2004. But there has been an overall increase in the quantity of
illicit drugs seized, particularly those destined for external markets. As one of the eval-
uation reports noted between 1995–99 and 2000–04, the amount of drugs seized in-
creased by 499 per cent: 116 per cent for cocaine, 134 per cent for hashish, 219
per cent for heroin and 1,526 per cent for ecstasy (Direccxa˜o Central de Investigacxa˜o
do Tra´fico de Estupefacientes 2004).
Annual data from the IDT provide further insight into the nature of the increases. In
particular, they reveal that in Portugal, there has not been a linear or constant increase
in the amounts seized (Instituto da Droga e da Toxicodependeˆncia 2009). Instead, there
have been spikes in seizures of a number of different substances with large seizures of
ecstasy between 2001 and 2003, hashish between 2003 and 2006, cocaine between 2004
and 2006 and even larger quantities of hashish between 2007 and 2008 (see Figure 4).
This is remarkably different from trends in Spain (see Figure 5), where there has been
an almost linear growth in cocaine and hashish seizure amounts (EMCDDA 2009b). It is
also different from Italy (see Figure 6), where there had been relatively flat trends with
no discernable spikes in hashish or ecstasy seizure quantities since 1999/2000.12 The
absence in Portugal of a consistent growth, in one product, and instead seizures of
a number of different products is much more in line with evidence of increased law
enforcement intervention as opposed to domestic growth in the market (as per the
Spanish trends).
Qualitative data from the Portuguese annual reports provide further evidence of high-
level law enforcement activities. For example, the Portuguese police have enhanced
their international collaborative efforts and introduced more systematic use of
12There were gaps in data on seizure quantities of cocaine in Italy between 1999 and 2004.











FIG. 4 Number of kilograms or pills seized in Portugal, by drug type, 1997–2008
Source: IDT (2009).













investigative techniques, which they argued ‘has allowed, over the last three years, to
increase the capacity of operational response with regard to drug trafficking by sea, par-
ticularly cocaine trafficking originating from South America’ (Institute for Drugs and
Drug Addiction 2008: 91).
At the same time, there have been reductions in the prices of most substances, par-
ticularly from 2001 levels. For example, the reported average price of 1 gram of heroin
decreased from $50.27 in 2001 to $33.25 in 2008 and the average price of an ecstasy
tablet fell from $6.86 in 2001 to $2.80 in 2008 (see Table 5). It is unclear whether drug
purity has also changed over this time.
The reductions in price may point to two phenomena: increased supply and reduced
demand. There are some indications from the school surveys of reduced use of canna-
bis, cocaine and ecstasy. The drug price data suggest that this was due to reduced de-
mand rather than the success in seizing drugs (which is supposed to limit drug use by
reducing availability and increasing price), but more detailed studies would be needed
to confirm this.
The declines in Portugal were somewhat different from neighbouring Spain (see
Table 6), where most retail drug prices have been stable. The exception is hash, as retail
prices have increased since 2001, which is argued to be in line with increasing demand.
Indeed, the lack of increase in the price of cocaine in Spain (and stable purity) is argued
to be odd, since other Spanish indicators suggest cocaine demand has been increasing.
Spanish experts therefore have suggested the lack of change is due to greater-than-
estimated levels of cocaine supply in Spain (Reitox National Focal Point 2008). These
indicators indicate that the Portuguese drug market, particularly local use of the drug
market, does not appear to have become rampant post decriminalization.
FIG. 6 Number of kilograms or pills seized in Italy, by drug type, 1997–2007
Source: EMCDDA (2009b).












The major perceived success of the Portuguese reform has been its contribution to
changes in public health problems, with significant referrals—particularly in the early
years—by the CDTs of heroin users to treatment. There have been significant reductions
in mortality, HIV, HCV and TB. Drug-related deaths are subject to changes in recording
as well as changes in underlying rates of drug use. Figure 7 shows that the number of
deaths in Portugal recorded as drug-related reduced significantly between 1999 and
2002 (Instituto da Droga e da Toxicodependeˆncia 2009).
Looking at neighbouring Italy and Spain, it is clear that trends in drug-related deaths
differ between the three nations, which reflect in part different stages of the heroin
epidemic (see Figure 7). The peak number of drug-related deaths occurred earlier
in Italy, in 1996, whereas both Portugal and Spain did not peak until 1999. That aside,
it is clear that since the Portuguese introduction of its drug strategy and the decrimi-
nalization, all three nations showed declines in drug-related deaths, but that the
declines were more pronounced in Portugal and Italy than in Spain. All three nations
showed a plateau in the mid 2000s but Portugal is unique in the recent increase. Nev-
ertheless, the subsequent increase has been attributed by local informants to a shift in
measurement practices, namely an increase in the number of toxicological autopsies
performed (from 1,166 in 2002 to 2,805 in 2008), which increased the probability that
people would be found to have drugs in their bodies at death. The proportion of deaths
in which opiates were the main substance in Portugal has continued on an almost steady
decline from 95 per cent in 1999 to 59 per cent in 2008 (55 per cent in 2007). Other
forms of drug-related deaths, especially due to cocaine, have risen in Spain but not Por-
tugal. For example, in Spain, cocaine has taken over from heroin as the major cause of
hospital admission and is the second most likely drug to be associated with death. Por-
tugal would appear to have been largely immune to this, with very low levels of cocaine
use, and the decriminalization would not appear to have disturbed this pattern.
TABLE 5 Average price for illicit substances in Portugal in Euros, by year and drug type, 1998–200813
Portugal 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Heroin (g) 38.50 31.33 49.72 50.27 43.78 46.80 46.54 41.01 42.17 37.57 33.25
Cocaine (g) 45.63 40.37 60.31 53.51 38.57 41.40 42.23 45.11 45.73 44.65 45.56
Hash (g) 1.78 1.09 4.13 4.06 2.45 2.49 2.31 2.13 2.18 3.45 3.28
Ecstasy (tablet) 11.70 6.70 5.98 6.86 5.90 5.27 4.50 3.56 3.18 3.20 2.80
Source: IDT (2009).
TABLE 6 Average price for illicit substances in Spain in Euros, by year and drug type, 2001–2007
Spain 2001 2002 2003 2004 2005 2006 2007
Heroin (g) 63.96 64.5 66.05 64.15 63.69 62.42 62.69
Cocaine (g) 59.70 58.29 61.90 61.85 60.58 60.66 60.75
Hash (g) 3.92 4.08 4.41 4.39 4.26 4.63 4.52
Ecstasy (tablet) 11.35 11.24 10.28 10.02 9.82 9.79 10.67
Source: Reitox National Focal Point (2008).
13Since 1st July 2001 when the decriminalization came into force the Criminal Police no longer collect data on price at street












Given that heroin problems were the major driver of the reform, this reduction in
overdose and opiate-related death was deemed by key informants as a considerable
achievement of both the decriminalization and the broader drug strategy. Reductions
in opiate-related deaths are likely to reflect the large increase in the provision and up-
take of treatment, particularly low-threshold opiate substitution treatments,14 and not
simply the effect of decriminalization. The overall numbers of drug users in treatment
expanded in Portugal from 23,654 to 38,532 between 1998 and 2008 (Instituto da Droga
e da Toxicodependeˆncia 2009).
The data on treatment clients—outpatient, inpatient and prescribed—all indicate
that the population of drug users has aged. For example, in 2000, only 23 per cent
of treatment clients admitted for the first time were aged over 34, but this rate has in-
creased steadily to a rate of 46 per cent in 2008 (Instituto da Droga e da Toxicodepen-
deˆncia 2009). Together with the data on the decline in the prevalence of problematic
drug use, this suggests an encouraging trend of reductions in the number of young peo-
ple who are becoming dependent on illicit drugs such as heroin.
The number of new drug users who are diagnosed with HIV and AIDS has also de-
clined. For example, between 2000 and 2008, the number of cases of HIV reduced
amongst drug users from 907 to 267 and the number of cases of AIDS reduced from
506 to 108 (Instituto daDroga e da Toxicodependeˆncia 2009). This is a highly significant
FIG. 7 Number of drug-related deaths recorded in Portugal, Spain and Italy, 1996–2008
Source: IDT (2009) and EMCDDA (2009b).
14Opiate-substitution treatments can be classified as being high or low-threshold, with the former involving very strict eligibility
criteria and treatment regimes that limit access to programmes and create additional demands on treatment providers and drug
users. Portugal traditionally only provided high-threshold treatment programmes, but following the 1990 roll-out of low-threshold
treatment programmes, they have become the most widely utilized form of treatment in Portugal.











trend that has been attributed primarily to the expansion of harm-reduction services.
A reduction in drug-related AIDS cases was also seen in Spain (from 5,085 cases in 1994
to 639 in 2007) following the scaling up of opiate substitution treatment (Brugal et al.
2005).
Discussion
In the first decade of this century, it has often been claimed that we are witnessing a gen-
eral shift towards punitive penal policies and the use of crime policies to legitimate neo-
liberal governance (Garland 2001; Simon 2007). The counter-example of Portugal,
which has seen both an extension of the welfare state and a reduction in the penali-
zation of vulnerable drug users, supports critics who have argued that such general the-
orizing underestimates the complexity of developments, both at home and abroad
(Hannah-Moffatt 2002; Zedner 2002; Young 2003; Loader and Sparks 2004; Hutchinson
2006). The appeal of the punitive turn in contemporary penality is by no means uni-
versal. Indeed, the Portuguese decriminalization stands in stark contrast to it, given its
adoption and continuation for reasons of human rights, social solidarity and acknowl-
edgement of the failure of punitive policies.
In the run-up to the 2009 general election, the incumbent Prime Minister gave
a speech in Lisbon at the European Monitoring Centre on Drugs and Drug Addiction
(So´crates 2009). He used this opportunity to boast publicly of his decisive role in the
introduction of the 2001 reform. He pledged his continuing support for it. Penal pop-
ulism was evidently not in play here.
Southern-European countries including Portugal, Italy and Spain have followed a dif-
ferent path from the neo-liberal, Anglo-Saxon economies. All had totalitarian regimes in
the last century. When emerging from dictatorship, all three nations adapted their con-
stitutions to recognize rights to citizenship and limit interference by the state in the
private lives of citizens. And all have undertaken changes within the criminal justice
arena to reduce criminalization by the state (Solivetti 2001; Gamella and Jime´nez
Rodrigo 2004). The need to examine the wider intellectual and political contexts in
which crime policy develops should also warn us against the temptation to attribute
changes in policy, or their effects, to the simple causal impacts of any particular,
one-off legal change. For example, we would dispute Greenwald’s (2009) tendency
to attribute positive changes in Portugal to decriminalization alone. Many other factors,
including expanded treatment services and an ageing population of heroin users, have
contributed to the positive results observed.
Yet, the reform provides important evidence for the debate on the impacts of decrim-
inalization. It demonstrates that—contrary to some predictions—decriminalization
does not inevitably lead to rises in drug use. It can reduce the burden upon the criminal
justice system. It can further contribute to social and health benefits. Moreover, such
affects can be observed when decriminalizing all illicit drugs. This is important, as
decriminalization is commonly restricted to cannabis alone.
Our research suggests that current theories and assumptions about decriminalization
are themselves in need of development. Decriminalization is often discussed as if it is
one, simple, unitary concept. But there are several forms of decriminalization in practice
internationally (Uitermark 2004; McLaren andMattick 2007; Babor et al. 2010). None of












Portuguese approach. Each of the models will have its own sources, costs and benefits,
which are in need of further research if we are to understand how they could be trans-
ferred across national borders.
Our studies of the Portuguese decriminalization over a number of years have further
illustrated the challenges in assessing the impacts from such a reform and the need to
recognize the importance of the timing of assessment in relation to implementation.
The effects of the Portuguese reforms appeared much less positive during the early
years, when implementation was more problematic (Hughes and Stevens 2007). Some
difficulties were an inevitable side effect of adopting a new reform. Others were less
controllable. These difficulties make it harder to compare impacts at a given time
against the potential future impacts of decriminalization. While there are calls in all
forms of research for repeated assessments, this is particularly necessary in regards
to decriminalization, where the heated debate makes such reforms particularly suscep-
tible to uninformed criticism.
Many reforms are evaluated only early on in their adoption, which may lead to un-
derestimation of their true impacts. One case in point is the South Australian cannabis
expiation notice scheme. The Portuguese (and South Australians) have therefore
done well to maintain the reform in spite of such difficulties. Other jurisdictions such
as Western Australia have not been so fortunate, and are in the process of overturning
a hard-fought-for reform (Barrett 2009).
Conclusion
In the Portuguese case, the statistical indicators and key informant interviews that we
have reviewed suggest that since decriminalization in July 2001, the following changes
have occurred:
 small increases in reported illicit drug use amongst adults;
 reduced illicit drug use among problematic drug users and adolescents, at least since
2003;
 reduced burden of drug offenders on the criminal justice system;
 increased uptake of drug treatment;
 reduction in opiate-related deaths and infectious diseases;
 increases in the amounts of drugs seized by the authorities;
 reductions in the retail prices of drugs.
By comparing the trends in Portugal and neighbouring Spain and Italy, we can say that
while some trends clearly reflect regional shifts (e.g. the increase in use amongst adults)
and/or the expansion of services throughout Portugal, some effects do appear to be
specific to Portugal. Indeed, the reduction in problematic drug users and reduction
in burden of drug offenders on the criminal justice system were in direct contrast to
those trends observed in neighbouring Spain and Italy. Moreover, there are no signs
of mass expansion of the drug market in Portugal. This is in contrast with apparent
market expansions in neighbouring Spain.
The problem is that it is impossible to state that any of these changes were the direct
result of the decriminalization policy. It also remains unclear whether the observed
impacts were influenced more by the policy or its implementation. Could better











implementation of the CDTmodel have led to better outcomes? This is an argument put
forward by many in government, but it is unfortunately untestable.
The information we have presented adds to the current literature on the impacts of
decriminalization. It disconfirms the hypothesis that decriminalization necessarily leads
to increases in the most harmful forms of drug use. While small increases in drug use
were reported by Portuguese adults, the regional context of this trend suggests that they
were not produced solely by the 2001 decriminalization. We would argue that they are
less important than themajor reductions seen in opiate-related deaths and infections, as
well as reductions in young people’s drug use. The Portuguese evidence suggests that
combining the removal of criminal penalties with the use of alternative therapeutic
responses to dependent drug users offers several advantages. It can reduce the burden
of drug law enforcement on the criminal justice system, while also reducing problematic
drug use.
A key implication of this article is the need for more nuanced discussions of decrim-
inalization, with acknowledgement of the different models and approaches that can be
adopted and of their various costs and benefits. A further implication is the need for
ongoing study of reforms over time. But, ultimately, the choice to decriminalize is not
simply a question of the research. It is also an ethical and political choice of how the state
should respond to drug use. Internationally, Portugal has gone furthest in emphasizing
treatment as an alternative to prosecution. Portuguese political leaders and professio-
nals have by and large determined that they have made the right policy choice and that
this is an experiment worth continuing. Portuguese policy makers suggest that adoption
of such a reform requires time to develop the infrastructure and the necessary collab-
oration between the criminal justice and health systems. They contend that such reform,
while not a swift or total solution, holds numerous benefits, principally of increased op-
portunity to integrate drug users and to address the causes and damages of drug use.
As this paper has shown, decriminalization of illicit drug use and possession does not
appear to lead automatically to an increase in drug-related harms. Nor does it eliminate
all drug-related problems. But it may offer a model for other nations that wish to provide
less punitive, more integrated and effective responses to drug use.
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